Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 15

1.

The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction.

Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, Klocke FJ, Bonow RO, Judd RM.

N Engl J Med. 2000 Nov 16;343(20):1445-53.

2.

Contrast-enhanced magnetic resonance imaging in the assessment of myocardial infarction and viability.

Saraste A, Nekolla S, Schwaiger M.

J Nucl Cardiol. 2008 Jan-Feb;15(1):105-17. doi: 10.1007/BF02976902. Epub 2007 Dec 21. Review.

PMID:
18242487
3.

Is cardiac magnetic resonance imaging assessment of myocardial viability useful for predicting which patients with impaired ventricles might benefit from revascularization?

Child NM, Das R.

Interact Cardiovasc Thorac Surg. 2012 Apr;14(4):395-8. doi: 10.1093/icvts/ivr161. Epub 2012 Jan 25. Review.

4.

Diagnostic and prognostic value of cardiac magnetic resonance imaging in assessing myocardial viability.

Kwong RY, Korlakunta H.

Top Magn Reson Imaging. 2008 Feb;19(1):15-24. doi: 10.1097/RMR.0B013e31817d550c. Review.

PMID:
18690157
5.

MRI assessment of myocardial viability: comparison with other imaging techniques.

Baer FM, Theissen P, Schneider CA, Kettering K, Voth E, Sechtem U, Schicha H.

Rays. 1999 Jan-Mar;24(1):96-108. Review. English, Italian.

PMID:
10358387
6.

[Magnetic resonance tomography imaging techniques for diagnosing myocardial vitality].

Baer FM, Theissen P, Schneider CA, Voth E, Schicha H, Sechtem U.

Herz. 1994 Feb;19(1):51-64. Review. German.

PMID:
8150414
7.

Magnetic resonance imaging in the assessment of ventricular remodeling and viability.

Jerosch-Herold M, Kwong RY.

Curr Heart Fail Rep. 2008 Mar;5(1):5-10. Review.

8.

Cardiac MR for the assessment of myocardial viability.

Van Assche LM, Kim HW, Kim RJ.

Methodist Debakey Cardiovasc J. 2013 Jul-Sep;9(3):163-8. Review.

9.

Revascularization in patients with chronic ischaemic myocardial dysfunction: insights from cardiovascular magnetic resonance imaging.

Bondarenko O, Beek AM, McCann GP, van Rossum AC.

Eur Heart J Cardiovasc Imaging. 2012 Dec;13(12):985-90. doi: 10.1093/ehjci/jes194. Epub 2012 Oct 2. Review.

10.

Revascularization in heart failure in the post-STICH era.

Jha S, Flamm SD, Kwon DH.

Curr Heart Fail Rep. 2013 Dec;10(4):365-72. doi: 10.1007/s11897-013-0168-2. Review.

PMID:
24142670
11.

Myocardial viability for decision-making concerning revascularization in patients with left ventricular dysfunction and coronary artery disease: a meta-analysis of non-randomized and randomized studies.

Orlandini A, Castellana N, Pascual A, Botto F, Cecilia Bahit M, Chacon C, Luz Diaz M, Diaz R.

Int J Cardiol. 2015 Mar 1;182:494-9. doi: 10.1016/j.ijcard.2015.01.025. Epub 2015 Jan 7. Review.

PMID:
25617608
12.

[Cardiac MRI: technology, clinical applications, and future directions].

Pesenti-Rossi D, Peyrou J, Baron N, Allouch P, Aubert S, Boueri Z, Livarek B.

Ann Cardiol Angeiol (Paris). 2013 Nov;62(5):326-41. doi: 10.1016/j.ancard.2013.08.010. Epub 2013 Aug 27. Review. French.

PMID:
24035258
13.

The viable myocardium: epidemiology, detection, and clinical implications.

Marwick TH.

Lancet. 1998 Mar 14;351(9105):815-9. Review.

PMID:
9519973
14.

No-reflow phenomenon in cardiac MRI: diagnosis and clinical implications.

Pineda V, Merino X, Gispert S, Mahía P, Garcia B, Domínguez-Oronoz R.

AJR Am J Roentgenol. 2008 Jul;191(1):73-9. doi: 10.2214/AJR.07.2518. Review.

PMID:
18562727
15.

Novel ways to noninvasively detect inflammation of the myocardium: contrast-enhanced MRI and myocardial contrast echocardiography.

van den Brink MR, Geluk CA, Lindner JR, Velthuis BK, Vonken EJ, Cramer MJ.

Neth Heart J. 2003 Apr;11(4):163-168. Review.

Items per page

Supplemental Content

Write to the Help Desk